Description

Health Canada recommends modified wording for the indications and clinical uses of fludeoxyglucose (F-18 FDG) products in their product monographs. The modified wording aims to bring the indications and clinical uses for F-18 FDG up-to-date and harmonize the product monographs in this regard.

Resources

Name	Format	Description	Link
Notice to stakeholders: Harmonizing fludeoxyglucose (F-18 FDG) product monographs	HTML		https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/harmonizing-fludeoxyglucose-product-monographs.html
Notice to stakeholders: Harmonizing fludeoxyglucose (F-18 FDG) product monographs	HTML		https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/harmonisation-monographies-produits-fluorodesoxyglucose.html

Tags

Topics

Categories